Neutrophil Influx and Chemokine Production during the Early Phases of the Antitumor Response to the Vascular Disrupting Agent DMXAA (ASA404)

5,6-Dimethylxanthenone-4-acetic acid (DMXAA) acts through tumor vascular disruption and cytokine production and is the first of its class to enter phase 3 trials. We characterized leukocytes and cytokines in murine Colon 38 tumors before and after DMXAA treatment. Tumor mass declined 50% 24 hours af...

Full description

Bibliographic Details
Main Authors: Liang-Chuan S. Wang, Lotte Thomsen, Rachel Sutherland, Charu B. Reddy, Sofian M. Tijono, Chun-Jen J. Chen, Catherine E. Angel, P. Rod Dunbar, Lai-Ming Ching
Format: Article
Language:English
Published: Elsevier 2009-08-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558609801358